P04.90. Review of pharmacoeconomic evaluations on Kampo medicine in Japan

被引:0
|
作者
W Tang
A Igarashi
K Tsutani
机构
[1] University of Tokyo,
来源
关键词
Herbal Medicine; Healthcare Resource; Health Practice; Primary Screening; Cost Study;
D O I
10.1186/1472-6882-12-S1-P360
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Reflections on the Research Status of Kampo Medicine:A Most Rewarding Visit to Japan
    徐浩
    殷惠军
    ChineseJournalofIntegrativeMedicine, 2010, 16 (04) : 357 - 360
  • [22] FEASIBILITY OF PHARMACOECONOMIC EVALUATIONS OF TRADITIONAL CHINESE MEDICINE FROM THE PERSPECTIVES OF THE HEALTH INSURANCE REVIEW & ASSESSMENT SERVICE IN SOUTH KOREA
    Lee, C.
    Wasserman, M.
    Guan, Q.
    VALUE IN HEALTH, 2014, 17 (07) : A801 - A801
  • [23] A SYSTEMATIC LITERATURE REVIEW OF PHARMACOECONOMIC EVALUATIONS FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN EUROPE
    Furnback, W.
    Yang, K.
    Chuang, P. Y.
    Chitale, R.
    Wang, B.
    Tang, B.
    VALUE IN HEALTH, 2020, 23 : S444 - S444
  • [24] Status of urological Kampo medicine: A narrative review and future vision
    Minagawa, Tomonori
    Ishizuka, Osamu
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (03) : 254 - 263
  • [25] A REVIEW OF PHARMACOECONOMIC EVALUATIONS OF NEW AND EXISTING TECHNOLOGIES BY THE NATIONAL CENTRE FOR PHARMACOECONOMICS IN IRELAND
    Tilson, L.
    O'Leary, A.
    Usher, C.
    Barry, M.
    VALUE IN HEALTH, 2009, 12 (07) : A250 - A250
  • [26] ANALYSIS OF DRUG-INDUCED INTERSTITIAL LUNG DISEASE CAUSED BY KAMPO MEDICINE IN JAPAN
    Suzuki, T.
    Saito, M.
    Mitsuma, T.
    Niitsuma, K.
    RESPIROLOGY, 2016, 21 : 191 - 191
  • [27] Overview of Cannabis including Kampo Medicine and Therapy for Treatment of Dementia: A Review
    Wenger, Tibor
    Watanabe, Kazuhito
    Sasaki, Yui
    Kanazawa, Keiko
    Shimizu, Koichi
    Sirikantaramas, Supaart
    Shoyama, Yoshinari
    Taura, Futoshi
    Morimoto, Satoshi
    Shoyama, Yukihiro
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [28] Traditional Chinese medicine and kampo: A review from the distant past for the future
    Yu, R.
    Takahashi, T.
    Moriya, J.
    Kawaura, K.
    Yamakawa, J.
    Kusaka, K.
    Itoh, T.
    Morimoto, S.
    Yamaguchi, N.
    Kanda, T.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2006, 34 (03) : 231 - 239
  • [29] HAS THE PUBLICATION OF CHINA GUIDELINES FOR PHARMACOECONOMIC EVALUATIONS 2020 INFLUENCED THE STUDY QUALITY OF ECONOMIC EVALUATIONS IN CHINA? A SYSTEMATIC REVIEW
    Cao, S.
    Liang, W.
    Liang, C.
    Lin, H.
    Gao, C.
    Yang, L.
    Liu, Y.
    Suo, Y.
    Liu, K.
    Chen, Y.
    Jin, X.
    VALUE IN HEALTH, 2023, 26 (12) : S557 - S557
  • [30] Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes - A systematic review on content and adherence to guidelines
    Vegter, Stefan
    Boersma, Cornelis
    Rozenbaum, Mark
    Wilffert, Bob
    Navis, Gerjan
    Postma, Maarten J.
    PHARMACOECONOMICS, 2008, 26 (07) : 569 - 587